Skip to content

Vericel VCEL Total debt

Total debt at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT
$20.95M+20.6%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
$14.78M+1,083%
Globus Medical logo
Globus MedicalGMED
$116.26M+25.0%
Stryker logo
StrykerSYK
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

Plus components not separately reported this period.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's total debt?
Vericel (VCEL) reported total debt of $95.04M in Q1 2026.
How has Vericel's total debt changed year-over-year?
Vericel's total debt decreased by 4.6% year-over-year, from $99.65M to $95.04M.
What is the long-term trend for Vericel's total debt?
Over 5 years (2020 to 2025), Vericel's total debt has grown at a 12.7% compound annual growth rate (CAGR), from $53.34M to $97.01M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.